Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with monoclonal antibody therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of trastuzumab plus docetaxel in treating women who have recurrent or metastatic breast cancer.
Key facts
- Study ID
- NCT00006104
- Run by
- Vanderbilt-Ingram Cancer Center
- People needed
- 46
- Starts
- 1998-09-01
- Expected to finish
- 2003-07-01
- Last updated by the study team
- 2012-08-14
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Providence Hospital — Mobile, Alabama, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
- Evanston Hospital — Evanston, Illinois, United States
- Owensboro Medical Health System — Owensboro, Kentucky, United States
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
- Erlanger Health Systems — Chattanooga, Tennessee, United States
- Memorial Health Care System — Chattanooga, Tennessee, United States
- Williamson Medical Center — Franklin, Tennessee, United States
- Jackson-Madison County Hospital — Jackson, Tennessee, United States
- Methodist/Thompson Oncology Research — Knoxville, Tennessee, United States
- Tennessee Cancer Specialists — Knoxville, Tennessee, United States
- Boston Baskin Cancer Group — Memphis, Tennessee, United States
- St. Thomas Health Services — Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
- Methodist Medical Center of Oak Ridge — Oak Ridge, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.